Skip to main content
Have a personal or library account? Click to login
Innate Lymphoid Cells: Roles In Tumour Genesis And Progression Cover

Innate Lymphoid Cells: Roles In Tumour Genesis And Progression

EABR. Experimental and Applied Biomedical Research
Volume 16 (2015): Issue 2 (June 2015)
By: ,  ,  ,  ,  ,   and    
Open Access
|Jun 2015
References

References

  1. 1. Tian Z, van Velkinburgh JC, Wu Y, Ni B. Innate lymphoid cells involve in tumourigenesis. Int J Cancer. 2015; doi: 10.1002/ijc.29443.
    Open DOISearch in Google Scholar
  2. 2. Fuchs A, Colonna M. Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumours of the gastrointestinal tract. Curr Opin Gastroenterol 2013; 29: 581-7.
    Open DOISearch in Google Scholar
  3. 3. Constantinides MG, McDonald BD, Verhoef PA, Bendelac A. A committed precursor to innate lymphoid cells. Nature 2014; 508: 397-401.
    Open DOISearch in Google Scholar
  4. 4. Spits H, Artis D, Colonna M et al. Innate lymphoid cells- a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13: 145-9.
    Open DOISearch in Google Scholar
  5. 5. Montaldo E, Vacca P, Moretta L, Mingari MC. Development of human natural killer cells and other innate lymphoid cells. Semin Immunol 2014; 26: 107-13.
    Open DOISearch in Google Scholar
  6. 6. Yagi R, Zhong C, Northrup DL et al. The transcription factor GATA3 is critical for the development of all IL-7Ralpha-expressing innate lymphoid cells. Immunity 2014; 40: 378-88.
    Open DOISearch in Google Scholar
  7. 7. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodelling. Nat Immunol 2011; 12: 21-7.
    Open DOISearch in Google Scholar
  8. 8. Jovanovic I, Pejnovic N, Radosavljevic G et al. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoural accumulation of immunosuppressive and innate lymphoid cells. Int J Cancer 2013; 134: 1669-82.
    Open DOISearch in Google Scholar
  9. 9. Liu J, Duan Y, Cheng X et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 2011; 407: 348-54.
    Open DOISearch in Google Scholar
  10. 10. Kirchberger S, Royston DJ, Boulard O et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013; 210: 917-31.
    Open DOISearch in Google Scholar
  11. 11. Ikutani M, Yanagibashi T, Ogasawara M et al. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumour immunity. J Immunol 2012; 188: 703-13.
    Open DOISearch in Google Scholar
  12. 12. Moro K, Yamada T, Tanabe M et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010; 463 (7280): 540-4.
    Open DOISearch in Google Scholar
  13. 13. Saenz SA, Siracusa MC, Perrigoue JG et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature. 2010; 464: 1362-6.
    Open DOISearch in Google Scholar
  14. 14. Neill DR, Wong SH, Bellosi A et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293): 1367-70.
    Open DOISearch in Google Scholar
  15. 15. Hurst SD, Muchamuel T, Gorman DM et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol. 2002; 169: 443-53.
    Open DOISearch in Google Scholar
  16. 16. Chang YJ, Kim HY, Albacker LA et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011; 12: 631-8.
    Open DOISearch in Google Scholar
  17. 17. Halim TY, Krauss RH, Sun AC, Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012; 36: 451-63.
    Open DOISearch in Google Scholar
  18. 18. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H. IL-33-responsive lineage-CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 2012; 188: 1503-13.
    Open DOISearch in Google Scholar
  19. 19. Barlow JL, Bellosi A, Hardman CS et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 2012; 129: 191-8.
    Open DOISearch in Google Scholar
  20. 20. Kim HY, Chang YJ, Subramanian S et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 2012; 129: 216-27.
    Open DOISearch in Google Scholar
  21. 21. Yasuda K, Muto T, Kawagoe T et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A. 2012; 109: 3451-6.
    Open DOISearch in Google Scholar
  22. 22. Wilhelm C, Hirota K, Stieglitz B et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 2011; 12: 1071-7.
    Open DOISearch in Google Scholar
  23. 23. Monticelli LA, Sonnenberg GF, Abt MC et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12: 1045-54.
    Open DOISearch in Google Scholar
  24. 24. Mirchandani AS, Salmond RJ, Liew FY. Interleukin-33 and the function of innate lymphoid cells. Trends Immunol 2012; 33: 389-96.
    Open DOISearch in Google Scholar
  25. 25. Kiessling, R. Klein, E., Pross, H. & Wigzell, H. “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukaemia cells. Characteristics of the killer cell. Eur. J. Immunol. 1975; 5: 117-121.
    Search in Google Scholar
  26. 26. Vonarbourg C, Mortha A, Bui VL et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt+ innate lymphocytes. Immunity 2010; 33: 736-751
    Open DOISearch in Google Scholar
  27. 27. Bernink JH, Peters CP, Munneke M et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol. 2013; 14: 221-9.
    Open DOISearch in Google Scholar
  28. 28. Klose CS, Flach M, Möhle L et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014; 157: 340–56.
    Open DOISearch in Google Scholar
  29. 29. Maloy KJ, Uhlig HH. ILC1 populations join the border patrol. Immunity 2013; 38: 630-2.
    Open DOISearch in Google Scholar
  30. 30. Cella M, Fuchs A, Vermi W et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457: 722-725.
    Open DOISearch in Google Scholar
  31. 31. Takayama T, Kamada N, Chinen H et al. Imbalance of NKp44(þ)NKp46(−) and NKp44(−) NKp46(þ) natural killer cells in the intestinal mucosa of patients with Crohn’s disease. Gastroenterology 2010; 139: 882-892
    Open DOISearch in Google Scholar
  32. 32. Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 2010; 107: 10961-10966.
    Open DOISearch in Google Scholar
  33. 33. Geremia A, Arancibia-Cárcamo CV, Fleming MP et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208:1127-1133.
    Open DOISearch in Google Scholar
  34. 34. Cupedo T, Crellin NK, Papazian N et al. Human foetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009; 10: 66-74.
    Open DOISearch in Google Scholar
  35. 35. Ivanov II, Diehl GE, Littman DR. Lymphoid tissue inducer cells in intestinal immunity. Curr Top Microbiol Immunol 2006; 308: 59-82.
    Open DOISearch in Google Scholar
  36. 36. Takatori H, Kanno Y, Watford WT et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009; 206: 35-41.
    Open DOISearch in Google Scholar
  37. 37. Hepworth MR, Monticelli LA, Fung TC et al. Innate lymphoid cells regulate T-cell responses to intestinal commensal bacteria. Nature 2013; 498: 113-117.
    Open DOISearch in Google Scholar
  38. 38. Plunkett TA, Correa I, Miles DW and Taylor-Papadimitriou J. Breast cancer and the immune system: opportunities and pitfalls. J. Mammary Gland Biol. Neoplasia 2001. 6: 467–475.
    Open DOISearch in Google Scholar
  39. 39. Ito N, Nakamura H, Tanaka Y and Ohgi S. Lung carcinoma: analysis of T-helper type 1 and 2 cells and T-cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry. Cancer 1999. 85: 2359–2367.
    Open DOISearch in Google Scholar
  40. 40. Nishimura T, Nakui M, Sato M et al. The critical role of Th1-dominant immunity in tumour immunology. Cancer Chemother. Pharmacol. 2000. 46: 52–61.
    Open DOISearch in Google Scholar
  41. 41. Dobrzanski MJ, Reome JB, Hylindand JC and Rewers-Felkins KA. CD8 mediated type 1 antitumour responses selectively modulate endogenous differentiated and nondifferentiated t cell localization, activation, and function in progressive breast cancer. J. Immunol. 2006. 177: 8191–8201.
    Open DOISearch in Google Scholar
  42. 42. Vujanovic NL, Basse P, Herberman RB and Whiteside TL. Antitumour functions of natural killer cells and control of metastasis. Methods 1996. 9: 394–408.
    Open DOISearch in Google Scholar
  43. 43. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D and Levitsky H. The central role of CD41 T cells in the antitumour immune response. J. Exp. Med. 1998. 188: 2357–2368.
    Open DOISearch in Google Scholar
  44. 44. Ellyard JI, Simson L, Parish CR. Th2-mediated antitumour immunity: friend or foe? Tissue Antigens 2007. 70: 1–11.
    Open DOISearch in Google Scholar
  45. 45. Stout RD and Bottomly K. Antigen-specific activation of effector macrophages by IFN-g producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function of macrophages. J. Immunol. 1989. 142: 760–765.
    Open DOISearch in Google Scholar
  46. 46. Hu HM, Urba WJ and Fox BA. Gene-modified tumour vaccine with therapeutic potential shifts tumour-specific T cell response from a type 2 to a type 1 cytokine profile. J. Immunol. 1998; 161: 3033-3041.
    Search in Google Scholar
  47. 47. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725-31.
    Open DOISearch in Google Scholar
  48. 48. Guedez L, Jensen-Taubman S, Bourboulia D et al. TIMP-2 targets tumour-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis. J Immunother 2012; 35: 502-12.
    Open DOISearch in Google Scholar
  49. 49. Koyasu S, Moro K. Type 2 innate immune responses and the natural helper cell. Immunology 2011; 132: 475-81.
    Open DOISearch in Google Scholar
  50. 50. Gabitass RF, Annels NE, Stocken DD et al. Elevated myeloid-derived suppressor cells in pancreatic, oesophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011; 60: 1419-30.
    Open DOISearch in Google Scholar
  51. 51. Li J, Razumilava N, Gores GJ et al. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest 2014; 124: 3241-51.
    Open DOISearch in Google Scholar
  52. 52. Patman G. Biliary tract. IL-33, innate lymphoid cells and IL-13 are required for cholangiocyte proliferation. Nat Rev Gastroenterol Hepatol 2014; 11: 456.
    Open DOISearch in Google Scholar
  53. 53. Pearson C, Uhlig HH, Powrie F. Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol 2012; 33: 289-96.
    Open DOISearch in Google Scholar
  54. 54. Chan IH, Jain R, Tessmer MS et al. Interleukin-23 is sufficient to induce rapid de novo gut tumourigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol 2014; 7: 842-56.
    Open DOISearch in Google Scholar
  55. 55. Murugaiyan G, Saha B. Protumour vs antitumour functions of IL-17. J Immunol 2009; 183: 4169-75.
    Open DOISearch in Google Scholar
  56. 56. Kamanaka M, Huber S, Zenewicz LA, et al. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J Exp Med 2011; 208: 1027-40.
    Open DOISearch in Google Scholar
  57. 57. Brand S, Beigel F, Olszak T, et al. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290: 827-38.
    Open DOISearch in Google Scholar
  58. 58. Vonarbourg C, Mortha A, Bui VL et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 2010; 33: 736-51.
    Open DOISearch in Google Scholar
  59. 59. Lim C, Savan R. The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev 2014; 25: 257-71.
    Open DOISearch in Google Scholar
  60. 60. Savan R, McFarland AP, Reynolds DA et al. A novel role for IL-22R1 as a driver of inflammation. Blood 2011; 117: 575-84.
    Open DOISearch in Google Scholar
  61. 61. Park O, Wang H, Weng H et al. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 2011; 54: 252-61.
    Open DOISearch in Google Scholar
  62. 62. Riccardi C, Santoni A, Barlozzari T, Puccetti P, Herberman RB. In vivo natural reactivity of mice against tumour cells. Int J Cancer 1980; 25: 475-486.
    Open DOISearch in Google Scholar
  63. 63. Wiltrout RH, Herberman RB, Zhang SR et al. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 1985; 134: 4267-4275.
    Open DOISearch in Google Scholar
  64. 64. Gorelik E, Herberman RB. Radioisotope assay for evaluation of in vivo natural cell-mediated resistance of mice to local transplantation of tumour cells. Int J Cancer 1981; 27: 709-720.
    Open DOISearch in Google Scholar
  65. 65. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB. Role of NK cells in the control of metastatic spread and growth of tumour cells in mice. Int J Cancer 1982; 30: 107-112.
    Open DOISearch in Google Scholar
  66. 66. Jovanovic I, Radosavljevic G, Milovanovic M et al. Suppressed Innate Immune Response against Mammary Carcinoma in BALB/C Mice. Ser J Exp Clin Res 2012; 13: 55-61.
    Open DOISearch in Google Scholar
  67. 67. Standish LJ, Sweet ES, Novack J et al. Breast cancer and the immune system. J Soc Integr Oncol 2008; 6: 158-168.
    Search in Google Scholar
  68. 68. Strayer DR, Carter WA, Mayberry SD et al. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer. Cancer Res 1984; 44: 370-374.
    Search in Google Scholar
  69. 69. Hacene K, Desplaces A, Brunet M, Lidereau R, Bourguignat A, Oglobine J. Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancer. Cancer 1986; 57: 245-250.
    Open DOISearch in Google Scholar
  70. 70. Mohanty I, Nayak M, Nanda BK. Cell mediated immune status in carcinoma breast. Indian J Pathol Microbiol 1991; 34: 1-6.
    Search in Google Scholar
  71. 71. Kauschke E, Komiyama K, Moro I, Eue I, König S, Cooper EL. Evidence for perforin-like activity associated with earthworm leukocytes. Zoology (Jena) 2001; 104: 13-24.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/sjecr-2015-0011 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 85 - 91
Submitted on: Mar 5, 2015
Accepted on: May 13, 2015
Published on: Jun 27, 2015
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Innate lymphoid cells,
tumour,
progression,
antitumor immunity
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2015 Ivan Jovanovic, Nevena Gajovic, Gordana Radosavljevic, Jelena Pantic, Nada Pejnovic, Nebojsa Arsenijevic, Miodrag L. Lukic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 16 (2015): Issue 2 (June 2015)
Next article